128 related articles for article (PubMed ID: 7562898)
1. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol.
Trenkwalder P; Elmfeldt D
J Hum Hypertens; 1995 Jul; 9 Suppl 2():S37-42. PubMed ID: 7562898
[TBL] [Abstract][Full Text] [Related]
2. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
3. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
Hosie J; Dahlöf B; Klein G
Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
5. A felodipine-metoprolol extended-release tablet: its properties and clinical development.
Dahlöf B; Andersson OK
J Hum Hypertens; 1995 Jul; 9 Suppl 2():S43-7. PubMed ID: 7562899
[TBL] [Abstract][Full Text] [Related]
6. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
7. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
Abrahamsson B; Edgar B; Lidman K; Wingstrand K
Blood Press Suppl; 1993; 1():10-5. PubMed ID: 8173686
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
Hoffmann J
Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
[TBL] [Abstract][Full Text] [Related]
9. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
[TBL] [Abstract][Full Text] [Related]
10. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
[TBL] [Abstract][Full Text] [Related]
11. Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group.
Brun J; Fröberg L; Kronmann P; Olsson LB; Skoog P; Tygesen G; Bengtsson C; Scherstén B; Tibblin G
J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S60-4. PubMed ID: 1693732
[TBL] [Abstract][Full Text] [Related]
12. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
[TBL] [Abstract][Full Text] [Related]
14. The effects of combining felodipine and metoprolol in moderate to severe hypertension--a one year study.
Chow J
J Hum Hypertens; 1988 Jun; 2(1):27-31. PubMed ID: 3236315
[TBL] [Abstract][Full Text] [Related]
15. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM; Goldberg AI
Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with felodipine and metoprolol compared with captopril and hydrochlorothiazide. German MC Study Group.
Klein G
Blood Press; 1998 Nov; 7(5-6):308-12. PubMed ID: 10321444
[TBL] [Abstract][Full Text] [Related]
18. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.
Haria M; Plosker GL; Markham A
Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104
[TBL] [Abstract][Full Text] [Related]
19. Critical assessment of combination therapy development.
Ménard J
Blood Press Suppl; 1993; 1():5-9. PubMed ID: 8173691
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol succinate combination in the treatment of hypertension.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
